SCHEMBL23780231

SCHEMBL23780231

CCOC(=O)C1COC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1869589 0.91 MAPT (0.43)
SCHEMBL22806878 0.85 MAPT (0.39)
SCHEMBL7666182 0.84 MAPT (0.45)
SCHEMBL5778032 0.82 PPM1B (0.43)
SCHEMBL11301518 0.81 ALDH1A1 (0.47)
SCHEMBL1867430 0.79 LMNA (0.42)
SCHEMBL11961324 0.79 MAPT (0.45)
SCHEMBL13282116 0.79 MEN1 (0.39)
SCHEMBL1863666 0.79 MAPT (0.38)
SCHEMBL28606445 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117957223-A Quinoline derivatives 礼蓝动物保健有限公司 2024-04-30 CN claimed
EP-3873608-A1 SUBSTITUTED 6-AZABENZIMIDAZOLE COMPOUNDS HAVING HPK1 INHIBITORY ACTIVITY GILEAD SCIENCES, INC. (US) 2021-09-08 EP disclosed